Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
18.51
+0.02 (0.11%)
Sep 2, 2026, 4:00 PM EDT - Market closed

Relay Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
121.1984.02124.29143.74151.79280.12
Short-Term Investments
789.75470.5657.04606.35847.12677.95
Cash & Short-Term Investments
910.93554.52781.32750.09998.92958.07
Cash Growth
38.70%-29.03%4.16%-24.91%4.26%41.30%
Receivables
----5.224.94
Prepaid Expenses
8.7417.7917.3516.712.1111.47
Other Current Assets
8.415.9710.533.323.261.76
Total Current Assets
928.08578.28809.2770.11,020976.24
Property, Plant & Equipment
38.0441.7257.6768.8775.3927.32
Other Intangible Assets
--2.32.32.32.3
Other Long-Term Assets
1.341.342.122.712.582.58
Total Assets
967.46621.33871.3843.981,1001,008

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
11.467.7114.19.2110.588.28
Accrued Expenses
34.0813.6521.2414.8922.713.56
Current Portion of Leases
4.013.775.734.964.281.84
Current Unearned Revenue
--7.68--0.25
Other Current Liabilities
1.250.461.991.226.150.4
Total Current Liabilities
50.825.5850.7330.2763.7124.32
Long-Term Leases
26.6428.6942.7848.553.4721.06
Other Long-Term Liabilities
---13.2132.3865.26
Total Liabilities
77.4554.2793.591.98149.55110.64

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.210.170.170.130.120.11
Additional Paid-In Capital
3,0632,5812,5172,1532,0191,667
Retained Earnings
-2,172-2,015-1,738-1,401-1,059-768.1
Comprehensive Income & Other
-1.550.73-0.99-0.2-10.42-1.09
Total Common Equity
890.01567.06777.79752950.22897.81
Shareholders' Equity
890.01567.06777.79752950.22897.81
Total Liabilities & Equity
967.46621.33871.3843.981,1001,008

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
30.6632.4648.553.4757.7422.9
Net Cash (Debt)
880.28522.06732.82696.62941.18935.17
Net Cash Growth
41.39%-28.76%5.20%-25.98%0.64%43.07%
Net Cash Per Share
4.833.045.135.688.399.83
Filing Date Shares Outstanding
219.14178.73169.52131.18121.38108.28
Total Common Shares Outstanding
218.53173.87167.76127.46121.11108.21
Working Capital
877.28552.7758.48739.83955.8951.92
Book Value Per Share
4.073.264.645.907.858.30
Tangible Book Value
890.01567.06775.49749.7947.92895.51
Tangible Book Value Per Share
4.073.264.625.887.838.28
Machinery
-22.3730.9329.0824.9817.88
Construction In Progress
--0.071.581.220.13
Leasehold Improvements
-0.913.833.833.832.9
SEC Filings: 10-K · 10-Q